1. A single oral dose of [14C]Ionox 100 to rats is almost entirely eliminated in 11 days: 89.1-107.2% of the 14C is excreted and 0'29 + 0.02% of the dose is present in the carcass plus viscera after removal of the gut. Rats exhibit an individual variation in the elimination pattern, 15.6-70-8% of 14C being excreted in the urine and 75.2-27.0% in the faeces during 11 days. 2. After the oral administration of [14C]Ionox 100 to dogs, 87.1-90.3% of the 140 is excreted in the faeces and urine during 4 days. 3. Dogs and rats do not show a species difference in this pattern of elimination. 4. The rate of elimination from dogs and rats given a single dose of Ionox 100 is not affected by the size ofthe dose and the presence oftriglyceride fat in the diet. 5. Ionox 100 is completely metabolized in dogs and rats: unchanged Ionox 100 is absent from the urine and faeces, and fromthe carcass when elimination is complete. In rats, 3,5-di-tert.-butyl-4-hydroxybenzoic acid accounts for 50-85% of a dose of Ionox 100 and (3,5-di-tert.-butyl-4-hydroxybenzoyl ,B-D-glucopyranosid)uronic acid for 47-10%; in dogs, the unconjugated acid accounts for 85% and the ester glucuronide for 10-12%. 3,5-Di-tert.-butyl-4-hydroxyhippuric acid is not formed. Other metabolites, which have been detected in small quantity in the faeces and urine of animals dosed with Ionox 100, have not been identified. 6.
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3,5-Di-tert.-butyl-4-hydroxybenzoic acid and (3,5-di-tert.-butyl-4-hydroxybenzoyl fl-D-glucopyranosid)uronic acid are also the major metabolites of Ionol (2,6-ditert.-butyl-p-cresol) in rats. 7. The elimination of Ionox 100 metabolites from rats is faster than that of Ionol and its metabolites. Unlike Ionol, unchanged Ionox 100 could not be detected in the bodies of these animals.
2,6-Di-tert.-butyl-4-hydroxymethylphenol (Ionox 100) protects a variety of chemical and biological products against oxidative attack (Morris & Rocklin, 1962) . Industrial application makes an understanding of the metabolism of this antioxidant desirable, because it may come into contact with food.
MATERIALS AND METHODS
General. Evaporations were carried out in N2 under reducedpressure below 35B. Meltingpoints were determined on a Kofler block. Specific rotations were determined in a 1 dm. micro-tube. Paper and thin-layer chromatography were carried out in a constant-temperature enclosure at 290 in all-glass apparatus. Chromatograms and thin-layer plates were dried at room temperature. The separation of lipids was effected in the dark. lonox 100. Technical lonox 100 was prepared by the method of Rocklin & Morris (1965) , described below for the preparation of the radioactive chemical, and was purified by chromatography on a column of acid-washed alumina of activity III (Brockmann & Schodder, 1941) , on to which it was adsorbed from solution in light petroleum (b.p. 60-800).
Elution with light petroleum-diethyl ether (7:3, v/v) (Coppinger & Campbell, 1953 The latter (5mg.), dissolved in 0-15m-sodium acetate buffer, pH4-2 (lOml.), was incubated with fl-glucuronidase (500 units) at 370 for 3hr., and the mixture extracted with ether. 3,5-Di-tert.-butyl-4-hydroxybenzoic acid was detected on paper chromatograms of the ether extract run in butan-1-ol-2N-NH3 with Gibb's reagent (Table 4) . Free glucuronio acid was detected with naphtharesorcinol (Tollens, 1908 (Tollens, ,1910 , and it was identified on paper chromatograms of the conoentrated aqueous phase run in butan-1-ol-acetic acid-water (4: 1: 1, by vol.) with naphtharesorcinol and p-anisidine hydrochloride (Hough; Jones & Wadman, 1950) . Isolation of methyl (3, tri-O-acetyl-fB-D-glucopyrano8id)uronate. Repetition of the foregoing separation gave an ether extract from the residual aqueous phase at pH 1-8, which was shown by paper chromatography to contain mainly (3,5-di-tert.-butyl-4-hydroxybenzoyl B-D-glucopyranosid)uronic acid and a trace of the unconjugated acid. A solution of this residue (4-1g.) in dry ether was methylated with excess of diazomethane in ether. The reaction mixture was kept at 00 for 16hr., when excess of solvent and reagent were removed, and the residue was acetylated at 250 with acetic anhydride (25ml.) and anhydrous pyridine (25ml.). The mixture was triturated with ice-water to yield an amorphous solid, which crystallized from aq. methanol as colourless prisms (2-5g.), m.p. 138-140°. This material was chromatographed on a silicic acid column (see Table 5 ). Calc. for C2sH3s012: C, 59-4; H, 6-8%). This compound was described by Dacre (1961) Experiments with animals. Adult rats (approx. 2 months old, 200g. body wt.) were used (Porton strain maintained as a specific pathogen-free colony in this Laboratory), and kept on sticks of food prepared by baking a standard pellet diet with eggs in cellophan tubing at 80-100' for 12hr. The animals were checked for general physical well-being and kept without food for 16hr. before experimental use. During experiments, the animals were kept singly in glass metabolism cages permitting the separate collection of urine, faeces and expired gases. The cages (Jencons of Hemel Hempstead, Herts.), designed for the study of the elimination pattern of radioactivity in rats dosed with a 14C0 or 3H-labelled compound, make use of some features previously described by Roth, Leifer, Hogness & Langham (1948) . A solution of [14C]Ionox 100 (16mg., 0-202,uc/mg.) in 3 ml. of olive oil was administered to each rat by stomach tube. Unrestricted food and water were supplied, and the urine and faeces were collected daily and stored at -29°. In this experiment, the rats were killed after 11 days, and the alimentary canal was removed. The carcass plus viscera, the alimentary canal and the skin and hair were stored separately at -29°. During the time when 14CO2 was being collected in the expired gases, the cages were ventilated at 700ml./min. and the exit was attached to two traps in series containing 4x-NaOH.
In another experiment with two rats, a solution of 25mg. of Ionol in 2ml. of olive oil was administered to each rat by stomach tube. Unrestricted food and water were supplied, and the urine and faeces were collected daily for 3 days.
Adult hounds (2-3 years old; 10-15kg. body wt.) were used (beagles maintained for 2-3 years as a closed colony in this Laboratory). They were maintained on a standard dry diet (Mor-meat). The animals were kept under observations for 7 days before experimental use, during which time they were checked for general physical well-being and for solidity of faeces. During experiments, the animals were housed singly in stainless-steel metabolism cages. (1) Gibb's reagent, a solution of 2,6-dichloro-p-benzoquinone-4-chloroimine (005%, w/v) in ethanol followed by aq. 4.75% (w/v) Na2B407,H20 buffer, pH9.3; (2) SbCl5 (Dobbs, 1963) .
RESULTS
In an experiment with six adult rats of each sex, which had been treated orally with-2,6-di-tert. Table 4 . RB values on paper and colour reactions of lonox 100 and its possible metabolites Rp values in parentheses are those of Dacre (1961) . lml. of olive oil. Absence of fat in the diet did not affect the rate of elimination of Ionox 100 metabolites from dogs. Radioactivity was recovered quantitatively from the urine of rats that had been treated with [14C]-Ionox 100 by successive ether extraction at pH 6-0 and pH 1-5-2-0. The ether extract prepared at pH6-0 from the 11-day urine contained half the amount of 14C found in that prepared at pH15-2 0. Paper chromatograms of representative samples of the ether extracts from each of the 24hr. urines from each of the 11 rats were run in two solvent systems and examined for radioactivity. Ionox 100 was not present amongst the metabolites in the urine. The single peak of 14C in extracts prepared at pH6-0 corresponded to 3,5-di-tert.-butyl-4-hydroxybenzoic acid. The major peak of 14C (95% of radioactivity in extract) in extracts prepared at pHl5-2 0 corresponded to (3,5-di-tert.-butyl-4-hydroxybenzoylf.-D-glucopyranosid)uronic acid, which was also located by Gibb's reagent and naphtharesoreinol on paper chromatograms (Table  4) of ether extracts similarly prepared from the urine of rabbits dosed with 3,5-di-tert.-butyl-4-hydroxybenzoic acid. There was also a small peak of 14C (4% of radioactivity in extract) due to the uncombined acid and a peak of 14C (1% of radioactivity in extract) due to an unknown component of R, 0.1 in the butan-1-ol-ammonia solvent. Vol. 97 307-product from successive methylation and acetylation was accordingly chromatographed on a silicic acid column (Table 5) . Two bands of radioactivity were separated, which contained respectively methyl 3,5-di-tert. -butyl-4-hydroxybenz[14C] oate, and methyl (3,5-di-tert.-butyl-4-hydroxybenz (Table  5) identical with material obtained from the metabolism of 3,5-di-tert.-butyl-4-hydroxybenzoic acid in rabbits and isolated by column chromatography on silicic acid from the crude reaction product after methylation and acetylation. 3,5-Ditert.-butyl-4-hydroxybenz[14C]oic acid, which accounts for 96% of the 14C in extracts of the faeces, was separated from the total lipid fraction of rat faeces by column chromatography on silicic acid (Table 6 ). The late fractions contained traces of three slow-moving radioactive components. Unchanged Ionox 100 was not eliminated in the faeces.
The detection of small amounts of 3,5-di-tert.-butyl-4-hydroxyhippuric acid in the urine ofrabbits treated orally with 3,5-di-tert.-butyl-4-hydroxybenzoic acid has been claimed (Dacre, 1961) , but after repetition of the work we could not find it. Some suspicion attached to the properties reported for this substance by Dacre (1961) , since the glycine conjugate would have been expected to give a deep-orange colour with Altman's reagent, which should fluoresce yellow in ultraviolet light, and since the R, of the glycine conjugate would have been expected to exceed that of the ester glucuronide in butan-l-ol-ammonia. By Schotten-Baumann reaction of 3,5-di-tert.-butyl-4-hydroxybenzoyl chloride and glycine in caustic alkali, we accordingly synthesized a small quantity of authentic 3,5-di-tert.-butyl-4-hydroxyhippuric acid, which had the colour reactions and Rp values (Table 4) that had been predicted for it; it was absent from the urine of rats dosed with lonox 100.
In conclusion, among the metabolic products of Ionox 100 in the rat, (3,5-di-tert.-butyl-4-hydroxybenzoyl fl-D-glucopyranosid)uronic acid accounts for 10-47% of the dose and 3,5-di-tert.-butyl-4-hydroxybenzoic acid accounts for 85-50% of the dose. In the dog, (3,5-di-tert.-butyl-4-hydroxybenzoyl P-D-glucopyranosid)uronic acid accounts for 10-12% of a dose of Ionox 100 and 3,5-di-tert.-butyl-4-hydroxybenzoic acid for 85% of the dose.
DISCUSSION
The expected general reaction of a primary aromatic alcohol in the animal body is oxidation to the corresponding aromatic acid, which is usually excreted as an ester glucuronide and a glycine conjugate. Benzyl (Bray, Thorpe & White, 1951) , phenethyl (El Masry, Smith & Williams, 1956; Smith, Smithies & Williams, 1954) and hydratropyl alcohols (Gruneberg & Langecker, 1957; Robinson, Smith & Williams 1955) are metabolized in this way, and the metabolism of Ionox 100 is therefore typical of an aromatic primary alcohol. There is no evidence that the aromatic nucleus undergoes hydroxylation, or that a tert.-butyl substituent is oxidized. The ester glucuronide is excreted in the urine together with variable quantities of uncombined aromatic acid. No glycine conjugate is synthesized by herbivores (rabbits), omnivores (rats) or carnivores (dogs), and this may be due to the lack ofreactivity of 3,5-di-tert.-butyl-4-hydroxybenzoic acid for the free glycine in the first glycine pool (Arnstein & Neuberger, 1951) .
The two structurally related antioxidants, Ionol (2,6-di-tert.-butyl-p-cresol) (I) and Ionox 100 (II) (Scheme 1), would be expected to have some metabolic products in common, and the present work shows that 3,5-di-tert.-butyl-4-hydroxybenzoic acid (III) and the related ester glucuronide (IV) are the major metabolites of Ionol and Ionox 100 in rats. The fact that lonol is oxidized in vivo at the 4-methyl group is contrary to the conclusion Vol. 97 309 drawn from the work of Goldber, Ryan & Wright (1962) and Ladomery, Ryan & Wright (1963) 
100.
The elimination of the metabolites of Ionox 100 from rats is undoubtedly more rapid than that of Ionol and its metabolic products, and, unlike Ionol, unchanged Ionox 100 could not be detected in the bodies of these animals. Thus rats, given [14C]Ionox 100 orally, eliminated 14C equivalent to 72.5-94.7% of the dose during 4 days, whereas rats dosed with [U-3H]Ionol excreted 3H equivalent to 20.0-49.0% of dose in the urine during that time (Goldber et al. 1962 ). Ionox 100 is completely metabolized in rats and, when elimination was complete, no unchanged Ionox 100 could be detected in extracts of the organs and tissues. The lipidsoluble Ionol is more stable to oxidation in vivo than lipid-soluble Ionox 100, and some deposition of unchanged Ionol in adipose tissue has been reported after high dosage ofIonol to rats (Johnson, O'Halloran & Hewgill, 1958) .
